‘Highly Problematic’: Acting FDA Commissioner Paused Planned OK Of Novavax Shot

 
• By Sarah Karlin-Smith
Novavax was expected to finally nab full approval of its COVID-19 vaccine on 1 April. (Shutterstock)

More from US FDA

More from Vaccines